COLTENE HOLDING sees an upgrade to Slightly Positive due to a better fundamental star rating
The general evaluation of COLTENE HOLDING (CH), a company active in the Medical Equipment industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 3 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date March 29, 2022, the closing price was CHF 104.80 and its potential was estimated at CHF 117.61.Coltene Holdings is engaged in the dental health care applications. Dentists and dental labs use COLTENE products for traditional, as well as implant-based therapies and dental reconstructions. After the sale of the entire medical business on Apr. 30, 2008, Co. is entirely engaged in the dental business. Under the umbrella brand Coltene/Whaledent, Co. develops, manufactures and sells via distribution channels a range of disposables and tools for dentists and dental laboratories. Co. maintains production facilities in the United States, Switzerland, Germany and Hungary.
Empowering Investors
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
- Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
- theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
- For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.